Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp. (TNXP): 6 pipeline candidates · 1 upcoming catalyst · ~14 mo cash runway · 5 clinical trials. Updated within the last hour.
BioSniper Score
6-factor signal · derived from public data
13.6 months
D/E 0.14 · 0% dilution
Lead: Approved
6 candidates
1 upcoming, next in ~2826d
4 buys · 0 sells (180d)
A transparent, data-derived signal for Tonix Pharmaceuticals Holding Corp.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$194.5M
Cash
$186.0M
Quarterly Burn
$42.3M
Runway
13.6 mo
Revenue
$6.9M
Cash Runway vs Catalysts
A catalyst falls after projected cash runway — potential financing / dilution risk before it hits.
Pipeline (6 candidates)
| Drug | Phase |
|---|---|
| keyhole limpet hemocyanin | Phase 1 |
| tnx-102 sl | Phase 2 |
| tnx-1300 | Phase 2 |
| tnx-1500 | Phase 2 |
| tnx-4800 | Phase 2 |
| tonmya | Approved |
Upcoming Catalysts (1)
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
80
Total value held
$68.3M
| Holder | Shares | Value |
|---|---|---|
| vanguard capital management llc | 1,037,300 | $14.3M |
| blackrock, inc. | 968,177 | $13.3M |
| citadel advisors llc | 511,812 | $7.0M |
| geode capital management, llc | 313,291 | $4.3M |
| balyasny asset management l.p. | 313,082 | $4.3M |
| state street corp | 230,607 | $3.2M |
| millennium management llc | 219,673 | $3.0M |
| aqr capital management llc | 161,208 | $2.2M |
| susquehanna international group, llp | 157,979 | $2.2M |
| point72 asset management, l.p. | 125,414 | $1.7M |
Showing top 10 of 80 institutional holders of Tonix Pharmaceuticals Holding Corp.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in Tonix Pharmaceuticals Holding Corp.'s pipeline?
Tonix Pharmaceuticals Holding Corp. (TNXP) has 6 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is Tonix Pharmaceuticals Holding Corp.'s lead drug candidate?
Tonix Pharmaceuticals Holding Corp.'s most advanced tracked candidate is keyhole limpet hemocyanin (Phase 1) for Phase 1 First-in-human Study Involving Healthy Subjects.
What is Tonix Pharmaceuticals Holding Corp.'s next catalyst?
Tonix Pharmaceuticals Holding Corp.'s next tracked catalyst is a Patent_Expiry event — "Patent/Exclusivity Expiry: TONMYA" — expected March 14, 2034.
What is Tonix Pharmaceuticals Holding Corp.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Tonix Pharmaceuticals Holding Corp. has approximately 13.6 months of cash runway.
What is Tonix Pharmaceuticals Holding Corp.'s market capitalization?
Tonix Pharmaceuticals Holding Corp.'s market capitalization is approximately $194.5M.
Get the full picture on Tonix Pharmaceuticals Holding Corp.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.